News and Views

Oncology nurse influence

The Case of the Resistance Relevance

Maria is a Black nurse who has worked at her institution’s cancer center for several years. She enjoys educating her colleagues about burnout and well-being to create a happier and healthier work environment and actively supports the institution’s diversity, equity, and inclusion (DEI) committee priorities and Black, Indigenous, and people of color (BIPOC) nurses in practice.

February 03, 2023

Trending Topics

View All Topics

Use Motivational Interviewing to Tailor Your Conversations to Your Patients’ Unique Needs

Patient Education

Use Motivational Interviewing to Tailor Your Conversations to Your Patients’ Unique Needs

February 02, 2023

Black Patients With Metastatic Breast Cancer Are Less Informed About Their Clinical Trial Options

Special Populations

Black Patients With Metastatic Breast Cancer Are Less Informed About Their Clinical Trial Options

February 01, 2023

FDA Approves Elacestrant for ER-Positive, HER2-Negative, ESR1-Variant Advanced or Metastatic Breast Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves Elacestrant for ER-Positive, HER2-Negative, ESR1-Variant Advanced or Metastatic Breast Cancer

January 31, 2023

Mentorships Open Opportunities for Oncology Nurses’ Career Growth and Wellness

Nurse well-being

Mentorships Open Opportunities for Oncology Nurses’ Career Growth and Wellness

January 31, 2023

Focus on COVID-19 Prevention Intensifies for Patients With Cancer as FDA Removes Emergency Use Authorization for Evushield

U.S. Food and Drug Administration (FDA)

Focus on COVID-19 Prevention Intensifies for Patients With Cancer as FDA Removes Emergency Use Authorization for Evushield

January 30, 2023

FDA Approves Pembrolizumab as Adjuvant Treatment for Non-Small Cell Lung Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves Pembrolizumab as Adjuvant Treatment for Non-Small Cell Lung Cancer

January 30, 2023

$FDA Grants Accelerated Approval to Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma$

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma

January 30, 2023

Oncology Drug Reference Sheet: Darolutamide

Drug Reference Sheet

Oncology Drug Reference Sheet: Darolutamide

January 26, 2023

Pancreatic Cancer Surveillance Programs Lead to Earlier Diagnoses and Better Outcomes

Pancreatic cancer

Pancreatic Cancer Surveillance Programs Lead to Earlier Diagnoses and Better Outcomes

January 25, 2023

Use Active Listening to Engage More Deeply in Patient Discussions

Use Active Listening to Engage More Deeply in Patient Discussions

January 24, 2023

FDA Approves Zanubrutinib for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

U.S. Food and Drug Administration (FDA)

FDA Approves Zanubrutinib for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

January 20, 2023

FDA Grants Accelerated Approval to Tucatinib With Trastuzumab for Colorectal Cancer

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Tucatinib With Trastuzumab for Colorectal Cancer

January 20, 2023

Aspirin’s Survival Benefits in Advanced CRC Depend on Patient BMI

Cancer research

Aspirin’s Survival Benefits in Advanced CRC Depend on Patient BMI

January 18, 2023

Genetic Disorder Reference Sheet: BAP1

Genetics & genomics

Genetic Disorder Reference Sheet: BAP1

January 17, 2023

Religious Fasting During Cancer Treatment

Cultural Competency

Religious Fasting During Cancer Treatment

January 17, 2023

Smiths Medical Issues Urgent Medical Device Correction Letter About Potential Issues With CADD™ Infusion Sets

U.S. Food and Drug Administration (FDA)

Smiths Medical Issues Urgent Medical Device Correction Letter About Potential Issues With CADD™ Infusion Sets

January 12, 2023

Spectrum Laboratory Products, Inc., Issues Voluntary Recall of Epinephrine USP, Bulk API, Because of Product Discoloration

U.S. Food and Drug Administration (FDA)

Spectrum Laboratory Products, Inc., Issues Voluntary Recall of Epinephrine USP, Bulk API, Because of Product Discoloration

January 12, 2023

The Case of the Costly PARP Inhibitor

The Case of the PARP Inhibitor Adherence Assistance

January 12, 2023

Text-Messaging Prescreening Streamlines Treatment Visits and Care for ICI Toxicities

Text-Messaging Prescreening Streamlines Treatment Visits and Care for ICI Toxicities

January 11, 2023

Achieve Equity in Patient Communication With These Evidence-Based Approaches

Special Populations

Achieve Equity in Patient Communication With These Evidence-Based Approaches

January 10, 2023

$FDA Grants Accelerated Approval to Mosunetuzumab-Axgb for Relapsed or Refractory Follicular Lymphoma$

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Mosunetuzumab-Axgb for Relapsed or Refractory Follicular Lymphoma

January 06, 2023

Hispanic Patients Are at Higher Risk for Aggressive Prostate Cancer but Less Likely to Get Treatment

Special Populations

Hispanic Patients Are at Higher Risk for Aggressive Prostate Cancer but Less Likely to Get Treatment

January 05, 2023

Hospira, Inc., Issues Voluntary Nationwide Recall for One Lot of Vancomycin Hydrochloride Injection, USP 1.5 g

U.S. Food and Drug Administration (FDA)

Hospira, Inc., Issues Voluntary Nationwide Recall for One Lot of Vancomycin Hydrochloride Injection, USP 1.5 g

January 04, 2023

Accord Healthcare, Inc., Issues Voluntary Recall for Lot of Daptomycin for Injection

U.S. Food and Drug Administration (FDA)

Accord Healthcare, Inc., Issues Voluntary Recall for Lot of Daptomycin for Injection

January 04, 2023

During or After Chemo, Exercise Fights Fatigue and Supports Cancer Recovery

During or After Chemo, Exercise Fights Fatigue and Supports Cancer Recovery

January 04, 2023

Demonstrate Your Scope of Practice by Becoming an Oncology Certified Nurse

Nurse empowerment

Demonstrate Your Scope of Practice by Becoming an Oncology Certified Nurse

January 03, 2023

Licensure, Scope of Practice, and Reporting

Ethics in nursing

Licensure, Scope of Practice, and Reporting

January 03, 2023

Let Your 2022 Achievements Lead You Even Higher in 2023

Let Your 2022 Achievements Lead You Even Farther in 2023

January 02, 2023

Build Your Confidence in Next-Generation Sequencing With Nursing Toolkits and Resources

Genetics & genomics

Build Your Confidence in Next-Generation Sequencing With Nursing Toolkits and Resources

December 29, 2022

Rural Patients Who Miss Radiation Doses Are More Likely to Die From Cancer

Radiation therapy

Rural Patients Who Miss Radiation Doses Are More Likely to Die From Cancer

December 28, 2022

Oncology APRNs Are Change Agents for Tobacco Cessation

Advanced Practice Nursing (APRN)

Oncology APRNs Are Change Agents for Tobacco Cessation

December 27, 2022

Redefining the Bell Makes the Ritual Inclusive for All Patients With Cancer

Patient empowerment

Redefining the Bell Makes the Ritual Inclusive for All Patients With Cancer

December 23, 2022

FDA Approves First Adenoviral Vector-Based Gene Therapy for High-Risk, BCG Unresponsive, Non–Muscle-Invasive Bladder Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves First Adenoviral Vector-Based Gene Therapy for High-Risk, BCG Unresponsive, Non–Muscle-Invasive Bladder Cancer

December 22, 2022

Chemo Combo May Be a Bladder Cancer Treatment Alternative During BCG Shortage

Chemo Combo May Be a Bladder Cancer Treatment Alternative During BCG Shortage

December 21, 2022

Oncology Drug Reference Sheet: Dostarlimab-Gxly

Drug Reference Sheet

Oncology Drug Reference Sheet: Dostarlimab-Gxly

December 20, 2022

FDA Approves Updated Drug Labeling Including New Indications and Dosing Regimens for Capecitabine Tablets Under Project Renewal

U.S. Food and Drug Administration (FDA)

FDA Approves Updated Drug Labeling Including New Indications and Dosing Regimens for Capecitabine Tablets Under Project Renewal

December 16, 2022

Wrap Up the Year With Reflection and Gratitude

Nurse well-being

Wrap Up the Year With Reflection and Gratitude

December 15, 2022

FDA Grants Accelerated Approval to Adagrasib for KRAS G12C–Variant Non-Small Cell Lung Cancer

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Adagrasib for KRAS G12C–Variant Non-Small Cell Lung Cancer

December 14, 2022

New Cancer Drugs Launch at Record-High Prices

Prescription medication

New Cancer Drugs Launch at Record-High Prices

December 14, 2022

Even During Routine Cancer Care, Financial Hardship Significantly Increases Mortality

Patient financial advocacy

Even During Routine Cancer Care, Financial Hardship Significantly Increases Mortality

December 13, 2022

FDA Approves Atezolizumab for Alveolar Soft Part Sarcoma

U.S. Food and Drug Administration (FDA)

FDA Approves Atezolizumab for Alveolar Soft Part Sarcoma

December 13, 2022

Overcome Inequalities in Cancer Treatment Options Across the Ages

Cancer treatments

Overcome Inequalities in Cancer Treatment Options Across the Ages

December 13, 2022

Oncology Nurse Navigator Roles Are Transforming Cancer Outcomes for Underserved Rural Patients

Nurse navigator

Oncology Nurse Navigator Roles Are Transforming Cancer Outcomes for Underserved Rural Patients

December 08, 2022

Engaging Community Health Workers Reduces Hospitalizations, Increases Psychosocial, Palliative, and EOL Care

End of life (EOL)

Engaging Community Health Workers Reduces Hospitalizations, Increases Psychosocial, Palliative, and EOL Care

December 07, 2022

Travel Nurses Bring Beneficial and Important Skills for Patient Care

Oncology nursing roles

Travel Nurses Bring Beneficial and Important Skills for Patient Care

December 06, 2022

Nontraditional Oncology Nursing Roles

Oncology nursing roles

Nontraditional Oncology Nursing Roles

December 06, 2022

$FDA Approves Olutasidenib for Relapsed or Refractory Acute Myeloid Leukemia With Susceptible IDH1 Variants$

U.S. Food and Drug Administration (FDA)

FDA Approves Olutasidenib for Relapsed or Refractory Acute Myeloid Leukemia With Susceptible IDH1 Variants

December 05, 2022

Join Us in Celebrating All That ONS Members Helped Us Achieve in 2022

Join Us in Celebrating All That ONS Members Helped Us Achieve in 2022

December 05, 2022

Genetic Disorder Reference Sheet: HOXB13

Genetics & genomics

Genetic Disorder Reference Sheet: HOXB13

November 30, 2022

Back to Top ▲